The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion.
Barbui T, Thiele J, Gisslinger H, Kvasnicka HM, Vannucchi AM, Guglielmelli P, Orazi A, Tefferi A. · 2018
Read The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion. by Barbui T, Thiele J, Gisslinger H, Kvasnicka HM, Vannucchi AM, Guglielmelli P, Orazi A, Tefferi A. (2018) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5807384.txt.
Description
Barbui and co-authors explain the 2016 WHO rules for myeloproliferative neoplasms. These are blood cancers where marrow makes too many cells. The world guide sorts them into seven types. Clear rules help doctors tell look-alike diseases apart.
Focus falls on three types tied to JAK2, CALR, or MPL gene faults. Tables lay out the test results each diagnosis needs. Changes sharpen the line between masked polycythemia vera and thrombocythemia. They also split early from advanced primary myelofibrosis. The authors flag disputes and give practice tips. Readers get a working guide to a complex rule change.
Catalog record
| CREATOR | Barbui T, Thiele J, Gisslinger H, Kvasnicka HM, Vannucchi AM, Guglielmelli P, Orazi A, Tefferi A. |
|---|---|
| YEAR | 2018 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 60 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |